NCT07131280View on ClinicalTrials.gov

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis

NANot yet recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2031

Study Completion Date

December 31, 2031

Conditions
Decompensated Cirrhosis
Interventions
DRUG

Gcsf

G-CSF will be given at a dose of 5 μg/kg s/c at days 1, 2, 3, 4, 5 and then every third and 7th day till day 30

DRUG

Darbepoetin

Darbepoetin will be given s/c at dose of 40mcg once a week for 1 month

OTHER

Standard Medical Treatment

Standard Medical Treatment

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
collaborator

Indian Council of Medical Research

OTHER_GOV

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT07131280 - National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis | Biotech Hunter | Biotech Hunter